MarketPeel
Insider Trading Intelligence
DP

Dinesh V. Ph D. Patel

PTGX
PRESIDENT AND CEO · PROTAGONIST THERAPEUTICS, INC · CIK 0001120477
FILING MIX · LIFETIME35%/65%
BUYS
33
SELLS
61
TOTAL VALUE
$47.12M
COMPANIES
1
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
225,000
AVG SELL PX
$60.88
TRADE KIND
SHOWING 94 / 94
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
21 backtested trades · 8 horizons · 37 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Dinesh V. Ph D. Patel, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d21+52.38%-0.81%+0.29%-1.37%-0.19%
14d21+61.90%-1.45%+0.33%-1.81%-1.11%
30d21+38.10%+2.74%+0.82%+1.93%+0.85%
60d21(1 pending)+30.00%+8.37%-1.45%+10.93%+13.88%
90d21(1 pending)+20.00%+16.08%+4.65%+11.43%+16.98%
180d21(8 pending)+7.69%+33.42%+5.82%+27.59%+39.11%
1y21(12 pending)+11.11%+57.74%+12.80%+44.94%+56.97%
2y21(15 pending)+33.33%+154.84%+26.95%+127.89%+151.70%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
PTGX · 225,000 shares · as of May 12, 2026
0154,806309,611464,417619,222202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 33 buys / 61 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
75,000225,000May 12, 2026May 12, 2026View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
75,000225,000May 12, 2026May 14, 2026View →
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASE
President and CEO
75,000$21.58$1.62M598,478May 12, 2026May 12, 2026View →
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASE
President and CEO
75,000$21.58$1.62M598,478May 12, 2026May 14, 2026View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
75,000$100.12$7.51M523,478May 12, 2026May 12, 2026View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE10b5-1
10b5-1 plan
75,000$100.12$7.51M523,478May 12, 2026May 14, 2026View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALEGRANT
Gift
1,460523,478Apr 23, 2026Apr 24, 2026View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
54,641$101.00$5.52M524,938Mar 25, 2026Mar 25, 2026View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
54,6410Mar 25, 2026Mar 25, 2026View →
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASE
President and CEO
54,641$8.58$468.8K579,579Mar 25, 2026Mar 25, 2026View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
5954,641Mar 24, 2026Mar 25, 2026View →
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASE
President and CEO
59$8.58$506524,997Mar 24, 2026Mar 25, 2026View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
59$101.00$6.0K524,938Mar 24, 2026Mar 25, 2026View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALEGRANT
Gift
50,000524,938Mar 23, 2026Mar 25, 2026View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
4,068300,000Jan 27, 2026Jan 27, 2026View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
4,068$83.19$338.4K574,505Jan 27, 2026Jan 27, 2026View →
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASE
President and CEO
4,068$21.58$87.8K578,573Jan 27, 2026Jan 27, 2026View →
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASE
President and CEO
14,205$21.58$306.5K588,710Jan 26, 2026Jan 27, 2026View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
10,6850Jan 26, 2026Jan 27, 2026View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
14,205$84.05$1.19M574,505Jan 26, 2026Jan 27, 2026View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
10,685$84.00$897.5K574,505Jan 26, 2026Jan 27, 2026View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
14,205304,068Jan 26, 2026Jan 27, 2026View →
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASE
President and CEO
10,685$4.21$45.0K585,190Jan 26, 2026Jan 27, 2026View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
19,31510,685Jan 23, 2026Jan 27, 2026View →
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASE
President and CEO
19,315$4.21$81.3K593,820Jan 23, 2026Jan 27, 2026View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALEGRANT
Gift
6,000574,505Jan 23, 2026Jan 27, 2026View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
19,315$84.59$1.63M574,505Jan 23, 2026Jan 27, 2026View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
34,438$82.48$2.84M580,505Jan 20, 2026Jan 21, 2026View →
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
120,200120,200Jan 2, 2026Jan 6, 2026View →
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
95,400614,943Jan 2, 2026Jan 6, 2026View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALEGRANT
Gift
440519,543Nov 21, 2025Nov 24, 2025View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALEGRANT
Gift
620519,983Sep 16, 2025Sep 18, 2025View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
10,415$54.78$570.5K520,603Jul 25, 2025Jul 28, 2025View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
17,520$54.79$959.9K531,018Jul 23, 2025Jul 23, 2025View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
22,065$55.05$1.21M548,538Jul 22, 2025Jul 23, 2025View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
12,859$54.86$705.4K570,603Jul 21, 2025Jul 23, 2025View →
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
25,000583,462Jul 21, 2025Jul 23, 2025View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALEGRANT
Gift
5,000558,462Jul 16, 2025Jul 18, 2025View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALEGRANT
Gift
685562,905Jun 16, 2025Jun 17, 2025View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALEGRANT
Gift
670563,590Jun 13, 2025Jun 17, 2025View →
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASE
President and CEO
24,000$4.21$101.0K564,260Mar 5, 2025Mar 5, 2025View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
24,00030,000Mar 5, 2025Mar 5, 2025View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
5,359$38.18$204.6K540,260Feb 19, 2025Feb 20, 2025View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
12,636545,619Jan 15, 2025Jan 17, 2025View →
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
181,472181,472Jan 2, 2025Jan 6, 2025View →
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
149,800558,255Jan 2, 2025Jan 6, 2025View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
21,480$46.25$993.5K408,455Nov 26, 2024Nov 27, 2024View →
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASE
President and CEO
1,727$21.58$37.3K429,935Nov 25, 2024Nov 27, 2024View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALEGRANT
Gift
7,000428,208Nov 25, 2024Nov 27, 2024View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
1,727318,273Nov 25, 2024Nov 27, 2024View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
78,520$46.96$3.69M435,208Nov 25, 2024Nov 27, 2024View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALEGRANT
Gift
1,000513,415Nov 19, 2024Nov 21, 2024View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALEGRANT
Gift
1,000514,415Jun 13, 2024Jun 17, 2024View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE10b5-1
10b5-1 plan
35,000$35.19$1.23M515,415Jun 7, 2024Jun 11, 2024View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE10b5-1
10b5-1 plan
25,000$28.31$707.8K549,590Apr 1, 2024Apr 2, 2024View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE10b5-1
10b5-1 plan
30,000$31.62$948.6K574,590Mar 1, 2024Mar 1, 2024View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
10,915$29.53$322.3K604,590Feb 26, 2024Feb 28, 2024View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
3,717$28.23$104.9K615,505Feb 15, 2024Feb 20, 2024View →
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
84,875619,222Jan 2, 2024Jan 4, 2024View →
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
315,250315,250Jan 2, 2024Jan 4, 2024View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE10b5-1
10b5-1 plan
75,000$20.08$1.51M534,347Dec 13, 2023Dec 15, 2023View →
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASE
President and CEO
6,000$4.21$25.3K609,347Oct 18, 2023Oct 19, 2023View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
6,00054,000Oct 18, 2023Oct 19, 2023View →
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
30,000615,111May 31, 2023Jun 2, 2023View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
12,165$26.07$317.1K602,946May 31, 2023Jun 2, 2023View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALEGRANT
Gift
10,000583,448Feb 22, 2023Jun 2, 2023View →
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
600,000600,000Jan 16, 2023Jan 18, 2023View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALEGRANT
Gift
3,116598,096Dec 28, 2022Jan 18, 2023View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
20,00060,000Aug 23, 2022Aug 24, 2022View →
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASE
President and CEO
20,000$4.21$84.2K604,048Aug 23, 2022Aug 24, 2022View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALEGRANT
Gift
3,000581,048May 4, 2022Jan 18, 2023View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
15,74280,000May 4, 2022May 4, 2022View →
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASE
President and CEO
15,742$4.21$66.3K584,048May 4, 2022May 4, 2022View →
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASE
President and CEO
30,000$4.21$126.3K568,306Apr 26, 2022Apr 26, 2022View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
30,00095,742Apr 26, 2022Apr 26, 2022View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
34,0870Apr 14, 2022Apr 14, 2022View →
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASE
President and CEO
34,087$1.89$64.4K537,847Apr 14, 2022Apr 14, 2022View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
4,648$24.28$112.9K503,760Feb 28, 2022Mar 2, 2022View →
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
31,250508,408Feb 15, 2022Feb 17, 2022View →
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
187,500187,500Feb 15, 2022Feb 17, 2022View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
15,000$32.14$482.2K477,158Dec 21, 2021Dec 23, 2021View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
40,000125,742Sep 21, 2021Sep 21, 2021View →
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASE
President and CEO
40,000$4.21$168.4K492,158Sep 21, 2021Sep 21, 2021View →
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
25,000451,144Feb 26, 2021Feb 26, 2021View →
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
225,000225,000Feb 26, 2021Feb 26, 2021View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
24,846$24.60$611.1K426,144Jan 19, 2021Jan 20, 2021View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
13,000165,742Jan 19, 2021Jan 20, 2021View →
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASE
President and CEO
13,000$4.21$54.7K450,990Jan 19, 2021Jan 20, 2021View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALEGRANT
Gift
2,000437,990Apr 29, 2020Apr 30, 2020View →
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASE
President and CEO
10,000$1.89$18.9K439,990Mar 20, 2020Mar 23, 2020View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
10,00034,087Mar 20, 2020Mar 23, 2020View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
President and CEO
18,3440Mar 12, 2020Mar 13, 2020View →
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASE
President and CEO
18,344$1.16$21.3K429,990Mar 12, 2020Mar 13, 2020View →
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
235,000235,000Feb 28, 2020Feb 28, 2020View →
Other insiders · PTGX
Loading peer insiders…
About this filer
CIK 0001120477
ROLE
President and CEO
PRIMARY
PTGX
COMPANIES
1
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001120477DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback